We are live on ! Find out more
BLFS icon

BioLife Solutions

169 hedge funds and large institutions have $1.31B invested in BioLife Solutions in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 52 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 52

23% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 22

7.1% more ownership

Funds ownership: 76.96%84.06% (+7.1%)

2% more funds holding

Funds holding: 165169 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less capital invested

Capital invested by funds: $1.34B → $1.31B (-$35.5M)

51% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $4.84M

Holders
169
Holders Change
+4
Holders Change %
+2.42%
% of All Funds
2.6%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
27
Increased
69
Reduced
52
Closed
22
Calls
$2.35M
Puts
$4.84M
Net Calls
-$2.49M
Net Calls Change
-$4.05M

BLFS Hedge Fund Activity: Q4 2021 in Review

169 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2021, worth a combined $1.31B — down 2.6% from $1.34B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BLFS positions and 22 closed out — a net gain of 5 holders — while 69 added to existing stakes and 52 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $72.7M. The largest seller was BlackRock, cutting an estimated $24.6M.

  • 169 institutional investors held BioLife Solutions (BLFS) as of Q4 2021, up from 165 in Q3 2021.
  • Funds reported $1.31B of BioLife Solutions stock for Q4 2021, down 2.6% quarter-over-quarter.
  • 27 funds opened new BioLife Solutions positions in Q4 2021 and 22 closed out, a net change of +5 holders.
  • The largest BioLife Solutions buyer in Q4 2021 was Fred Alger Management, an estimated $72.7M added.
  • The largest BioLife Solutions seller in Q4 2021 was BlackRock, an estimated $24.6M sold.

Based on aggregated 13F filings for Q4 2021.